Active Biotech provides updated information about the company's financial position
December 10 2018 - 6:30AM
PRESS RELEASE
As announced in connection with the interim report
for January-September 2018 Active Biotech has requested, from the
bank that finances the company's property in Lund, that the agreed
deadline for the disposal of the property (by December 31, 2018)
should be removed. Active Biotech has a continued dialogue with the
bank and, as expected, agreed with the bank that the process of
divestment of the property will continue even after the turn of the
year, in continuous consultation with the bank, and that the loan
agreement will continue on otherwise unchanged terms.
Lund, December 10, 2018
Active Biotech AB (publ)
Helén Tuvesson
President and CEO
For further information, please
contact:
Helén Tuvesson, President and CEO
Tel. +46 46 19 21 56
Hans Kolam, CFO
Tel. +46 46 19 20 44
Active Biotech AB (publ)
(NASDAQ Stockholm: ACTI) is a biotechnology company with focus on
neurodegenerative/inflammatory diseases and cancer. Laquinimod, an
orally administered small molecule with unique immunomodulatory
properties in development for neurodegenerative diseases. ANYARA,
an immunotherapy, in development for cancer indications in
partnership with NeoTX Therapeutics Ltd. Furthermore, commercial
activities are conducted for the tasquinimod, paquinimod and SILC
projects. Please visit www.activebiotech.com for more
information.
Active Biotech AB
(Corp. Reg. No. 556223-9227)
Box 724, SE-220 07 Lund, Sweden
Tel: +46 (0)46 19 20 00
This information is information
that Active Biotech AB is obliged to make public pursuant to the EU
Market Abuse Regulation. This information was submitted for
publication, through the agency of the contact person set out
above, at 12.30 p.m. CET
on December 10, 2018.
Active Biotech - updated info about
the company's financial position
This
announcement is distributed by West Corporation on behalf of West
Corporation clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Active Biotech via Globenewswire
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Sep 2023 to Sep 2024